Enza Palazzo Selected Research

Enza Palazzo Research Topics

Disease

32	Pain (Aches) 01/2022 - 05/2004
24	Neuralgia (Stump Neuralgia) 01/2021 - 10/2006
22	Hyperalgesia 01/2022 - 05/2004
9	Chronic Pain 01/2021 - 08/2010
5	Cognitive Dysfunction 01/2021 - 06/2015
3	Peripheral Nerve Injuries 01/2021 - 01/2011
2	Mood Disorders (Mood Disorder) 01/2022 - 03/2004
2	Mental Disorders (Mental Disorder) 01/2019 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 02/2014
1	Weight Gain 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2021
1	Neurobehavioral Manifestations 01/2021
1	Epilepsy (Aura) 01/2017
1	Brain Concussion (Cerebral Concussion) 01/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2015
1	Ataxia (Dyssynergia) 02/2015
1	Bronchial Hyperreactivity 01/2015
1	Respiratory Hypersensitivity 01/2015
1	Acute Pain 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Nervous System Diseases (Neurological Disorders) 02/2014
1	Arthritis (Polyarthritis) 12/2011
1	Visceral Pain 04/2011
1	Inflammation (Inflammations) 01/2011

Drug/Important Bio-Agent (IBA)

13	Glutamic Acid (Glutamate)FDA Link 01/2021 - 05/2004
12	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 09/2008
8	metabotropic glutamate receptor 7IBA 01/2020 - 09/2008
8	Analgesics (Analgesic Drugs)IBA 01/2018 - 12/2007
7	metabotropic glutamate receptor 8IBA 01/2020 - 09/2008
6	LigandsIBA 01/2017 - 08/2010
5	Serotonin (5 Hydroxytryptamine)IBA 10/2015 - 05/2004
5	Formaldehyde (Formol)FDA Link 09/2013 - 05/2004
4	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 07/2007
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2019 - 12/2009
4	palmidrolIBA 04/2019 - 01/2011
4	CarrageenanIBA 03/2013 - 05/2004
4	CannabinoidsIBA 03/2012 - 10/2006
4	EndocannabinoidsIBA 03/2012 - 03/2006
3	salicylhydroxamic acid (SHAM)IBA 04/2019 - 10/2015
3	PlasticsIBA 01/2015 - 01/2011
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2012 - 08/2010
3	TRPV1 receptorIBA 10/2010 - 04/2008
3	anandamide (arachidonylethanolamide)IBA 01/2009 - 10/2006
2	2-pentadecyl-2-oxazolineIBA 01/2022 - 01/2021
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022 - 01/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 01/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2015
2	Metabotropic Glutamate 5 ReceptorIBA 04/2019 - 05/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 03/2011
2	N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA 01/2018 - 12/2011
2	D-Aspartic Acid (D Aspartate)IBA 01/2016 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2011
2	Mesylates (Mesylate)IBA 03/2012 - 10/2006
1	2- amino- 4- (3- hydroxy- 5- methylisoxazol- 4- yl)butyric acidIBA 01/2022
1	Heavy MetalsIBA 06/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	LY 235959IBA 09/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2019
1	N-Methylaspartate (NMDA)IBA 09/2019
1	Neuroprotective AgentsIBA 04/2019
1	N-acylethanolaminesIBA 01/2019
1	metabotropic glutamate receptor 2IBA 01/2018
1	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2018
1	ADX71743IBA 01/2018
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2016
1	Homer Scaffolding Proteins (Homer 1)IBA 01/2016
1	SolutionsIBA 01/2016
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2016
1	7- hydroxy- 3- (4- iodophenoxy)- 4H- chromen- 4- oneIBA 06/2015
1	N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamideIBA 02/2015
1	MT2 Melatonin ReceptorIBA 02/2015
1	acetamideIBA 02/2015
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2015
1	OvalbuminIBA 01/2015
1	AllergensIBA 01/2015
1	GABA-A Receptors (GABA(A) Receptor)IBA 03/2013
1	metabotropic glutamate receptor type 1IBA 03/2013
1	BicucullineIBA 03/2013
1	AMPA Receptors (AMPA Receptor)IBA 11/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2012
1	CaspasesIBA 11/2012
1	salvinorin AIBA 08/2012
1	CationsIBA 02/2012
1	ONO-DI-004IBA 10/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2011
1	ProdrugsIBA 04/2011
1	Arginine (L-Arginine)FDA Link 04/2011
1	Monosaccharide Transport ProteinsIBA 04/2011
1	EstersIBA 04/2011
1	vesicular GABA transporterIBA 03/2011
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2011
1	arachidonoylserotoninIBA 01/2011

Therapy/Procedure

5	Analgesia 01/2022 - 12/2009
3	Ligation 01/2021 - 02/2015
2	Therapeutics 01/2017 - 01/2011
1	Operative Surgical Procedures 01/2018
1	Pain Management 02/2012